26.06.2017 15:27:00
|
Sinovac Biotech To Be Acquired By Parent For Around $401.8 Mln
(RTTNews) - Sinovac Biotech Ltd. (SVA) Monday said it has entered into a definitive amalgamation agreement with the parent Sinovac (Cayman) Limited and Sinovac Amalgamation Sub Limited to be acquired by Parent in a transaction valued at approximately $401.8 million.
Pursuant to the Amalgamation Agreement, Parent will acquire Sinovac Biotech for cash consideration equal to $7.00 per common share. This represents a premium of 32.1 percent and 30 percent, respectively, over the Company's 30- and 60-trading day volume-weighted average price.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sinovac Biotech LtdShsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Sinovac Biotech LtdShsmehr Analysen
Aktien in diesem Artikel
Sinovac Biotech LtdShs | 6,47 | -0,31% |
|